How do we measure adherence to anti-tuberculosis treatment?

S Valencia, M León, I Losada, VG Sequera… - Expert review of anti …, 2017 - Taylor & Francis
Introduction: Completion of anti-tuberculosis (TB) treatment is of paramount importance for
TB patients, as well as for the global efforts of TB control. However, there is neither a gold …

Evaluating the impact of the DREAMS partnership to reduce HIV incidence among adolescent girls and young women in four settings: a study protocol

I Birdthistle, SB Schaffnit, D Kwaro, M Shahmanesh… - BMC Public Health, 2018 - Springer
Background HIV risk remains unacceptably high among adolescent girls and young women
(AGYW) in southern and eastern Africa, reflecting structural and social inequities that drive …

A systematic review of non-pharmacological interventions to improve therapeutic adherence in tuberculosis

D Riquelme-Miralles, A Palazón-Bru, A Sepehri… - Heart & Lung, 2019 - Elsevier
Background Reviews examining non-pharmacological interventions to improve therapeutic
adherence in tuberculosis have several limitations (design, quality assessment…) …

People-and patient-centred care for tuberculosis: models of care for tuberculosis

A Odone, B Roberts, M Dara… - … of tuberculosis and …, 2018 - ingentaconnect.com
SETTING: The first pillar in the World Health Organisation's (WHO's) End TB strategy is
'Integrated, patient-centred tuberculosis (TB) care and prevention'. However, what are …

People–centred care versus clinic–based DOT for continuation phase TB treatment in Armenia: A cluster randomized trial

V Khachadourian, N Truzyan, A Harutyunyan… - BMC Pulmonary …, 2020 - Springer
Background WHO's directly observed therapy (DOT) strategy for tuberculosis (TB) treatment
depends upon a well–organized healthcare system. This study sought to evaluate the …

[HTML][HTML] To end TB, first-ever high-level meeting on tuberculosis must address stigma

A Daftary, EMH Mitchell, MJA Reid… - The American Journal …, 2018 - ncbi.nlm.nih.gov
World leaders gather to consolidate their commitment to ending tuberculosis (TB). Vital to
the success of renewed efforts is an overdue recognition of the pervasive and pernicious …

Development and assessment of novel machine learning models to predict medication non-adherence risks in type 2 diabetics

M Li, X Lu, HB Yang, R Yuan, Y Yang… - Frontiers in Public …, 2022 - frontiersin.org
Background Medication adherence is the main determinant of effective management of type
2 diabetes, yet there is no gold standard method available to screen patients with high-risk …

Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trial

JJ Lewis, X Liu, Z Zhang, BV Thomas, A Vassall… - Trials, 2018 - Springer
Background Treatment for drug-sensitive tuberculosis (TB) is taken for at least 6 months and
problems with adherence are common. Therefore, there is substantial interest in the …

[HTML][HTML] Toward developing a standardized core set of outcome measures in mobile health interventions for tuberculosis management: systematic review

S Lee, Y Lee, S Lee, SMS Islam… - JMIR mHealth and …, 2019 - mhealth.jmir.org
Background: Tuberculosis (TB) management can be challenging in low-and middle-income
countries (LMICs) not only because of its high burden but also the prolonged treatment …

Nursing in adherence to treatment of tuberculosis and health technologies in the context of primary care

RCA Temoteo, JBL Carvalho, ALBC Lira, MA Lima… - Escola Anna …, 2019 - SciELO Brasil
Objective: To describe and analyze the relationships between adherence to tuberculosis
treatment and health technologies in the context of nursing action in Primary Care. Method …